Finance

Lists
ANNX:STO
Annexin Pharmaceuticals AB (publ)
SEK 9.04
+1.12%
(+0.10) 1D
Nov 13, 5:29:37 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ANNX...
Open
SEK 8.62
High
SEK 9.04
Low
SEK 8.32
Mkt. cap
78.81M
Avg. vol.
7.59K
Volume
0.00
52-wk high
SEK 26.99
52-wk low
SEK 6.24
EPS
-SEK 5.81
Shares outstanding
8.72M
No. of employees
4
Open
SEK 8.62
High
SEK 9.04
Low
SEK 8.32
Mkt. cap
78.81M
Avg. vol.
7.59K
Volume
0.00
52-wk high
SEK 26.99
52-wk low
SEK 6.24
EPS
-SEK 5.81
Shares outstanding
8.72M
No. of employees
4
News stories
From web sources and news partners
About Annexin Pharmaceuticals AB (publ)
CEO-
Employees4
Founded2014
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteannexinpharma.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.00M
7.92M
8.48M
6.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.26M
2.90M
2.96M
2.61M
Operating expense
10.26M
10.82M
11.14M
9.50M
Total operating expenses
10.26M
10.82M
11.14M
9.50M
Operating income
-10.26M
-10.82M
-11.14M
-9.50M
Other non operating income
-
-
1.00K
-
EBT including unusual items
-10.52M
-10.52M
-11.56M
-9.49M
EBT excluding unusual items
-10.52M
-10.52M
-11.56M
-9.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-288.00K
-
Net income
-10.52M
-10.52M
-11.56M
-9.49M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
231.00K
34.00K
-
-
Interest expense
-
-
-
-
Net interest expenses
231.00K
34.00K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.21M
-10.77M
-11.10M
-9.45M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps